Tricuspid Valve Disease
Conditions
Keywords
Tricuspid regurgitation, tricuspid valve, surgery, outcome, prognosis, mortality, right ventricle, asymptomatic
Brief summary
The tricuspid valve : its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified.
Detailed description
The tricuspid valve is often called the "forgotten valve" because its evaluation is relatively difficult in echocardiography and the management of tricuspid valve diseases remains poorly codified. In developed countries, TR is mainly functional, related to a remodeling of the right cavities in response to an increase in the load conditions. This remodeling induces a dilation of the tricuspid ring and / or a "tenting" of the tricuspid leaflets. Once TR is present, a vicious circle settles because TR increases right ventricle dilation. Transthoracic echocardiography is the key examination allowing noninvasive, quantification and assessment of hemodynamic repercussions of TR. TR remains asymptomatic for a long time, often diagnosed with a significant delay at the stage of advanced right heart failure. At this stage, the surgical risk is important, at least more important than for left heart valve diseases and it is therefore essential to define the right time for proposing valvular surgery to patients. Indeed, TR is an independent factor of mortality and only surgical treatment improves the prognosis. Current guidelines remain vague given the low number of prognostic studies and of their contradictory results often influenced by the significant comorbidities of patients, the presence of pulmonary hypertension or left heart valve disease. Only a minority of patients (\<1%) is referred to surgery because operative mortality is often judged unacceptable in elderly patients or in cases of advanced right ventricular dysfunction. The constitution of a prospective and retrospective cohort will improve the state of knowledge on etiologies, natural history, prognosis and management of patients with moderate or severe TR.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Age \>18 ans * inclusion criteria: moderate or severe tricuspid regurgitation *
Exclusion criteria
Refusal to participate/ prior surgery of the tricuspid valve
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Overall survival | 5 Years | It corresponds to the delay between the diagnostic and the date of death. |
Countries
France
Contacts
CHU AMIENS-PICARDIE